Published in Blood Weekly, June 29th, 2006
According to a recent report from Japan, "The realization of regenerative cardiac medicine depends on the availability of cardiomyocytes in sufficient numbers for transplantation of cardiac tissue and the accompanying blood vessels. Embryonic stem (ES) cells, bone marrow (BM) stem cells, and tissue-derived stem cells are all potential cell sources."
"Although ES cells are highly proliferative and suitable for mass production," said K. Fukuda and colleagues at Keio University, School of Medicine, "an efficient protocol is yet to be established to ensure selective...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.